23andMe, GlaxoSmithKline deal raising concerns over privacy
Fox News medical correspondent Dr. Marc Siegel on the promising signs in Biogen's Alzheimer's new treatment, GlaxoSmithKline buying a stake in 23andMe and the potential privacy concerns over the genetic service.
0 comments:
Post a Comment